| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Depressive Disorder | 46 | 2019 | 222 | 9.460 |
Why?
|
| Mental Health Services | 26 | 2022 | 154 | 7.610 |
Why?
|
| Suicide | 27 | 2022 | 123 | 7.550 |
Why?
|
| Suicide, Attempted | 22 | 2022 | 96 | 7.440 |
Why?
|
| Depression | 46 | 2023 | 502 | 7.380 |
Why?
|
| Antidepressive Agents | 42 | 2023 | 155 | 7.220 |
Why?
|
| Suicidal Ideation | 19 | 2022 | 100 | 6.580 |
Why?
|
| Psychotherapy | 20 | 2019 | 58 | 6.470 |
Why?
|
| Mental Disorders | 21 | 2022 | 280 | 5.220 |
Why?
|
| Self-Injurious Behavior | 6 | 2022 | 44 | 4.310 |
Why?
|
| Humans | 186 | 2023 | 17611 | 4.230 |
Why?
|
| Bipolar Disorder | 20 | 2019 | 59 | 3.610 |
Why?
|
| Adult | 107 | 2022 | 7598 | 3.450 |
Why?
|
| Pragmatic Clinical Trials as Topic | 8 | 2021 | 57 | 3.130 |
Why?
|
| Middle Aged | 94 | 2022 | 7911 | 3.090 |
Why?
|
| Male | 106 | 2022 | 10008 | 2.980 |
Why?
|
| Female | 124 | 2022 | 12608 | 2.930 |
Why?
|
| Psychotic Disorders | 5 | 2019 | 44 | 2.910 |
Why?
|
| Electronic Health Records | 18 | 2022 | 681 | 2.840 |
Why?
|
| Research Design | 9 | 2021 | 374 | 2.590 |
Why?
|
| Drug Prescriptions | 9 | 2016 | 151 | 2.490 |
Why?
|
| Depressive Disorder, Major | 17 | 2022 | 124 | 2.440 |
Why?
|
| Primary Health Care | 23 | 2019 | 766 | 2.310 |
Why?
|
| Adolescent | 48 | 2022 | 3651 | 2.300 |
Why?
|
| Telemedicine | 8 | 2022 | 182 | 2.130 |
Why?
|
| Risk Assessment | 11 | 2021 | 1097 | 2.090 |
Why?
|
| Aged | 56 | 2022 | 6095 | 2.040 |
Why?
|
| Patient Care Management | 6 | 2022 | 30 | 1.910 |
Why?
|
| Psychiatric Status Rating Scales | 21 | 2019 | 125 | 1.900 |
Why?
|
| Community Mental Health Services | 5 | 2016 | 33 | 1.850 |
Why?
|
| Young Adult | 30 | 2020 | 2427 | 1.810 |
Why?
|
| Substance-Related Disorders | 7 | 2021 | 434 | 1.780 |
Why?
|
| United States | 42 | 2020 | 3956 | 1.770 |
Why?
|
| Delivery of Health Care, Integrated | 7 | 2019 | 531 | 1.710 |
Why?
|
| Firearms | 3 | 2022 | 32 | 1.690 |
Why?
|
| Patient Dropouts | 4 | 2015 | 22 | 1.680 |
Why?
|
| Obesity | 16 | 2011 | 837 | 1.680 |
Why?
|
| Mental Health | 7 | 2022 | 165 | 1.590 |
Why?
|
| Health Care Costs | 12 | 2012 | 228 | 1.550 |
Why?
|
| Treatment Outcome | 28 | 2019 | 1259 | 1.510 |
Why?
|
| Surveys and Questionnaires | 27 | 2022 | 1309 | 1.480 |
Why?
|
| Anxiety Disorders | 7 | 2019 | 91 | 1.440 |
Why?
|
| Psychiatry | 7 | 2020 | 23 | 1.380 |
Why?
|
| International Classification of Diseases | 2 | 2022 | 85 | 1.350 |
Why?
|
| Comorbidity | 20 | 2023 | 594 | 1.330 |
Why?
|
| Time Factors | 14 | 2020 | 1086 | 1.330 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2019 | 382 | 1.320 |
Why?
|
| Outcome Assessment (Health Care) | 8 | 2017 | 228 | 1.310 |
Why?
|
| Information Dissemination | 2 | 2020 | 51 | 1.280 |
Why?
|
| Risk Factors | 27 | 2022 | 3325 | 1.280 |
Why?
|
| Washington | 23 | 2020 | 374 | 1.210 |
Why?
|
| Schizophrenia | 3 | 2019 | 77 | 1.190 |
Why?
|
| Health Services | 5 | 2022 | 112 | 1.140 |
Why?
|
| Delivery of Health Care | 7 | 2021 | 415 | 1.120 |
Why?
|
| Ethnic Groups | 4 | 2020 | 485 | 1.060 |
Why?
|
| Cooperative Behavior | 4 | 2015 | 91 | 1.060 |
Why?
|
| Machine Learning | 3 | 2022 | 46 | 1.030 |
Why?
|
| Internet | 6 | 2022 | 231 | 1.020 |
Why?
|
| Telephone | 10 | 2015 | 161 | 1.010 |
Why?
|
| Medication Adherence | 4 | 2016 | 244 | 1.010 |
Why?
|
| Severity of Illness Index | 15 | 2015 | 454 | 0.960 |
Why?
|
| Follow-Up Studies | 19 | 2018 | 1210 | 0.920 |
Why?
|
| Mood Disorders | 4 | 2009 | 19 | 0.920 |
Why?
|
| Health Personnel | 4 | 2015 | 124 | 0.890 |
Why?
|
| Precision Medicine | 3 | 2018 | 28 | 0.880 |
Why?
|
| Continuity of Patient Care | 4 | 2011 | 105 | 0.880 |
Why?
|
| Patient Health Questionnaire | 2 | 2021 | 18 | 0.870 |
Why?
|
| Biomedical Research | 3 | 2021 | 86 | 0.870 |
Why?
|
| Patient Care | 2 | 2022 | 35 | 0.860 |
Why?
|
| Cost-Benefit Analysis | 14 | 2018 | 250 | 0.860 |
Why?
|
| Informed Consent | 2 | 2021 | 19 | 0.830 |
Why?
|
| Models, Statistical | 2 | 2021 | 177 | 0.810 |
Why?
|
| Patient Education as Topic | 6 | 2012 | 211 | 0.810 |
Why?
|
| Self Care | 8 | 2015 | 163 | 0.800 |
Why?
|
| Evidence-Based Practice | 2 | 2020 | 46 | 0.790 |
Why?
|
| Outpatients | 5 | 2021 | 107 | 0.780 |
Why?
|
| National Institutes of Health (U.S.) | 4 | 2017 | 26 | 0.770 |
Why?
|
| Managed Care Programs | 6 | 2011 | 325 | 0.770 |
Why?
|
| Ambulatory Care | 12 | 2018 | 244 | 0.760 |
Why?
|
| European Continental Ancestry Group | 3 | 2019 | 529 | 0.740 |
Why?
|
| Drug Therapy | 3 | 2012 | 18 | 0.730 |
Why?
|
| Emergency Service, Hospital | 3 | 2022 | 358 | 0.720 |
Why?
|
| Psychotropic Drugs | 3 | 2018 | 36 | 0.720 |
Why?
|
| Mental Recall | 2 | 2012 | 31 | 0.720 |
Why?
|
| Benchmarking | 1 | 2020 | 46 | 0.690 |
Why?
|
| Medical Informatics | 2 | 2017 | 38 | 0.690 |
Why?
|
| Quality of Health Care | 3 | 2019 | 326 | 0.690 |
Why?
|
| Models, Psychological | 1 | 2019 | 23 | 0.690 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 17 | 0.680 |
Why?
|
| Data Accuracy | 1 | 2019 | 27 | 0.670 |
Why?
|
| Medical Informatics Applications | 1 | 2019 | 8 | 0.660 |
Why?
|
| Patient Compliance | 7 | 2012 | 298 | 0.650 |
Why?
|
| Dysthymic Disorder | 3 | 2017 | 6 | 0.650 |
Why?
|
| Patient Care Planning | 2 | 2018 | 52 | 0.640 |
Why?
|
| Inpatients | 1 | 2019 | 81 | 0.640 |
Why?
|
| Self Report | 6 | 2021 | 251 | 0.620 |
Why?
|
| Community-Institutional Relations | 2 | 2016 | 43 | 0.610 |
Why?
|
| Minority Groups | 2 | 2020 | 101 | 0.610 |
Why?
|
| Self-Help Groups | 2 | 2016 | 30 | 0.610 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 1900 | 0.590 |
Why?
|
| Case-Control Studies | 10 | 2022 | 1115 | 0.590 |
Why?
|
| Disease | 1 | 2017 | 5 | 0.580 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 201 | 0.580 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2017 | 2 | 0.580 |
Why?
|
| Arthritis, Psoriatic | 1 | 2017 | 5 | 0.580 |
Why?
|
| Psoriasis | 1 | 2017 | 9 | 0.580 |
Why?
|
| Therapy, Computer-Assisted | 3 | 2012 | 10 | 0.570 |
Why?
|
| Evidence-Based Medicine | 2 | 2011 | 185 | 0.570 |
Why?
|
| Social Support | 2 | 2016 | 203 | 0.560 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2017 | 9 | 0.560 |
Why?
|
| Cause of Death | 2 | 2016 | 181 | 0.550 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2017 | 6 | 0.550 |
Why?
|
| Rural Health Services | 2 | 2013 | 13 | 0.540 |
Why?
|
| Hotlines | 1 | 2016 | 14 | 0.540 |
Why?
|
| Psychotherapy, Group | 4 | 2015 | 26 | 0.540 |
Why?
|
| Health Services Research | 7 | 2019 | 231 | 0.530 |
Why?
|
| Self-Management | 1 | 2016 | 28 | 0.530 |
Why?
|
| Weight Loss | 5 | 2016 | 303 | 0.520 |
Why?
|
| Electronic Mail | 3 | 2014 | 51 | 0.510 |
Why?
|
| Retrospective Studies | 14 | 2023 | 2447 | 0.510 |
Why?
|
| Body Mass Index | 8 | 2011 | 958 | 0.510 |
Why?
|
| Cross-Sectional Studies | 10 | 2021 | 1322 | 0.510 |
Why?
|
| Patient Satisfaction | 4 | 2012 | 211 | 0.490 |
Why?
|
| Idaho | 6 | 2013 | 24 | 0.490 |
Why?
|
| Patient Care Team | 3 | 2016 | 113 | 0.480 |
Why?
|
| Pregnancy Complications | 5 | 2017 | 196 | 0.480 |
Why?
|
| Behavior Therapy | 4 | 2022 | 146 | 0.470 |
Why?
|
| Preventive Health Services | 4 | 2017 | 159 | 0.460 |
Why?
|
| Pneumonia | 1 | 2014 | 51 | 0.460 |
Why?
|
| Death | 1 | 2013 | 10 | 0.460 |
Why?
|
| Off-Label Use | 1 | 2013 | 14 | 0.450 |
Why?
|
| Medicaid | 2 | 2013 | 186 | 0.450 |
Why?
|
| Child Abuse | 2 | 2012 | 43 | 0.450 |
Why?
|
| Health Maintenance Organizations | 9 | 2007 | 417 | 0.450 |
Why?
|
| Benzodiazepines | 2 | 2019 | 27 | 0.440 |
Why?
|
| Logistic Models | 9 | 2019 | 926 | 0.440 |
Why?
|
| Antipsychotic Agents | 1 | 2013 | 49 | 0.440 |
Why?
|
| Chronic Disease | 9 | 2012 | 428 | 0.440 |
Why?
|
| Medical History Taking | 1 | 2012 | 35 | 0.420 |
Why?
|
| Patient Preference | 1 | 2013 | 48 | 0.420 |
Why?
|
| Women's Health | 2 | 2011 | 200 | 0.420 |
Why?
|
| Patient Readmission | 1 | 2014 | 163 | 0.420 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 238 | 0.410 |
Why?
|
| Cross-Cultural Comparison | 2 | 2004 | 15 | 0.410 |
Why?
|
| Basal Ganglia | 1 | 2012 | 1 | 0.400 |
Why?
|
| Reversal Learning | 1 | 2012 | 1 | 0.400 |
Why?
|
| Anhedonia | 1 | 2012 | 5 | 0.400 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 4 | 2006 | 30 | 0.400 |
Why?
|
| Prevalence | 10 | 2017 | 884 | 0.390 |
Why?
|
| Age Factors | 6 | 2020 | 917 | 0.390 |
Why?
|
| Deductibles and Coinsurance | 1 | 2012 | 30 | 0.390 |
Why?
|
| Health Surveys | 7 | 2016 | 260 | 0.390 |
Why?
|
| Health Care Surveys | 6 | 2016 | 230 | 0.390 |
Why?
|
| Learning | 1 | 2011 | 10 | 0.390 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 103 | 0.380 |
Why?
|
| Cognition | 1 | 2012 | 81 | 0.380 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2009 | 85 | 0.370 |
Why?
|
| Peer Group | 1 | 2011 | 48 | 0.370 |
Why?
|
| Community Health Centers | 1 | 2011 | 64 | 0.360 |
Why?
|
| Odds Ratio | 5 | 2015 | 671 | 0.360 |
Why?
|
| Cost of Illness | 4 | 2004 | 92 | 0.360 |
Why?
|
| Longitudinal Studies | 9 | 2019 | 710 | 0.360 |
Why?
|
| Employment | 2 | 2008 | 42 | 0.360 |
Why?
|
| Prepaid Health Plans | 2 | 2007 | 20 | 0.350 |
Why?
|
| Bias | 2 | 2016 | 102 | 0.350 |
Why?
|
| Patient Participation | 1 | 2011 | 133 | 0.350 |
Why?
|
| Confidence Intervals | 5 | 2012 | 237 | 0.340 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 598 | 0.340 |
Why?
|
| Mass Screening | 6 | 2019 | 661 | 0.340 |
Why?
|
| Incidence | 5 | 2020 | 1255 | 0.340 |
Why?
|
| Diabetes Mellitus | 4 | 2007 | 487 | 0.340 |
Why?
|
| Risk | 5 | 2019 | 516 | 0.330 |
Why?
|
| Feeding and Eating Disorders | 1 | 2009 | 17 | 0.330 |
Why?
|
| Diffusion of Innovation | 1 | 2009 | 42 | 0.330 |
Why?
|
| Confidentiality | 2 | 2017 | 27 | 0.330 |
Why?
|
| Heart Failure | 1 | 2014 | 396 | 0.330 |
Why?
|
| Diagnosis-Related Groups | 1 | 2009 | 24 | 0.320 |
Why?
|
| Diabetes Complications | 3 | 2005 | 114 | 0.320 |
Why?
|
| Case Management | 1 | 2009 | 32 | 0.320 |
Why?
|
| Consumer Behavior | 1 | 2009 | 29 | 0.320 |
Why?
|
| Cohort Studies | 7 | 2022 | 2570 | 0.310 |
Why?
|
| Activities of Daily Living | 2 | 2009 | 85 | 0.300 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2013 | 330 | 0.300 |
Why?
|
| Registries | 2 | 2020 | 471 | 0.300 |
Why?
|
| Oceanic Ancestry Group | 2 | 2019 | 33 | 0.300 |
Why?
|
| Indians, North American | 2 | 2019 | 49 | 0.300 |
Why?
|
| Absenteeism | 5 | 2007 | 24 | 0.290 |
Why?
|
| Clinical Trials as Topic | 3 | 2017 | 130 | 0.290 |
Why?
|
| Physician-Patient Relations | 1 | 2009 | 187 | 0.290 |
Why?
|
| Disabled Persons | 2 | 2005 | 35 | 0.280 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2017 | 58 | 0.280 |
Why?
|
| Asian Americans | 2 | 2019 | 176 | 0.280 |
Why?
|
| Hypnotics and Sedatives | 1 | 2006 | 18 | 0.270 |
Why?
|
| Smoking | 1 | 2009 | 483 | 0.270 |
Why?
|
| Forecasting | 2 | 2021 | 75 | 0.270 |
Why?
|
| Colorado | 2 | 2017 | 163 | 0.270 |
Why?
|
| Interviews as Topic | 7 | 2010 | 305 | 0.270 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2005 | 197 | 0.260 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 351 | 0.260 |
Why?
|
| Formularies as Topic | 1 | 2005 | 2 | 0.260 |
Why?
|
| Physicians, Family | 2 | 2007 | 44 | 0.260 |
Why?
|
| Pregnant Women | 2 | 2017 | 45 | 0.260 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2002 | 9 | 0.250 |
Why?
|
| Hispanic Americans | 2 | 2019 | 404 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2020 | 322 | 0.250 |
Why?
|
| Prognosis | 4 | 2018 | 606 | 0.250 |
Why?
|
| Heart Diseases | 2 | 2005 | 77 | 0.250 |
Why?
|
| Health Status | 7 | 2020 | 298 | 0.250 |
Why?
|
| Child | 7 | 2022 | 2474 | 0.240 |
Why?
|
| Health Expenditures | 1 | 2005 | 75 | 0.240 |
Why?
|
| Prenatal Diagnosis | 2 | 2014 | 17 | 0.240 |
Why?
|
| Serotonin Uptake Inhibitors | 2 | 2001 | 71 | 0.230 |
Why?
|
| Complementary Therapies | 1 | 2004 | 46 | 0.230 |
Why?
|
| Disease Progression | 4 | 2018 | 264 | 0.230 |
Why?
|
| Workload | 2 | 2020 | 30 | 0.220 |
Why?
|
| Alcohol Drinking | 3 | 2020 | 368 | 0.220 |
Why?
|
| Poverty | 2 | 2017 | 166 | 0.220 |
Why?
|
| Decision Making | 3 | 2018 | 183 | 0.220 |
Why?
|
| Continental Population Groups | 2 | 2015 | 302 | 0.220 |
Why?
|
| Congenital Abnormalities | 1 | 2002 | 26 | 0.210 |
Why?
|
| Drug Costs | 2 | 2004 | 34 | 0.210 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 37 | 0.210 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2006 | 39 | 0.210 |
Why?
|
| Pandemics | 2 | 2022 | 287 | 0.200 |
Why?
|
| Combined Modality Therapy | 4 | 2010 | 145 | 0.190 |
Why?
|
| Ethics Committees, Research | 1 | 2021 | 10 | 0.190 |
Why?
|
| Qualitative Research | 1 | 2022 | 254 | 0.190 |
Why?
|
| Socioeconomic Factors | 3 | 2020 | 630 | 0.190 |
Why?
|
| Hypochondriasis | 1 | 2001 | 1 | 0.190 |
Why?
|
| Chronic Pain | 1 | 2023 | 127 | 0.190 |
Why?
|
| Work | 3 | 2006 | 10 | 0.190 |
Why?
|
| Workers' Compensation | 1 | 2001 | 7 | 0.190 |
Why?
|
| Feasibility Studies | 2 | 2012 | 114 | 0.190 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 568 | 0.190 |
Why?
|
| Child, Preschool | 4 | 2022 | 1409 | 0.180 |
Why?
|
| Databases as Topic | 1 | 2000 | 19 | 0.180 |
Why?
|
| Quality Improvement | 1 | 2022 | 189 | 0.180 |
Why?
|
| Likelihood Functions | 2 | 2012 | 44 | 0.180 |
Why?
|
| Reproducibility of Results | 4 | 2014 | 381 | 0.180 |
Why?
|
| Disease Management | 2 | 2020 | 135 | 0.180 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2002 | 160 | 0.180 |
Why?
|
| Attitude to Health | 4 | 2014 | 164 | 0.180 |
Why?
|
| Pregnancy | 7 | 2020 | 1494 | 0.180 |
Why?
|
| Grief | 1 | 2020 | 3 | 0.180 |
Why?
|
| Bereavement | 1 | 2020 | 4 | 0.180 |
Why?
|
| Psychology | 1 | 2020 | 16 | 0.180 |
Why?
|
| Eligibility Determination | 1 | 2020 | 12 | 0.180 |
Why?
|
| Sample Size | 1 | 2020 | 29 | 0.180 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 47 | 0.180 |
Why?
|
| Physician's Role | 1 | 2020 | 31 | 0.170 |
Why?
|
| Feedback | 1 | 2000 | 19 | 0.170 |
Why?
|
| Somatoform Disorders | 1 | 1999 | 6 | 0.170 |
Why?
|
| Comparative Effectiveness Research | 1 | 2020 | 66 | 0.170 |
Why?
|
| Body Weight | 3 | 2010 | 219 | 0.170 |
Why?
|
| Network Meta-Analysis | 1 | 2019 | 3 | 0.170 |
Why?
|
| Algorithms | 1 | 2021 | 233 | 0.170 |
Why?
|
| Sleep Wake Disorders | 1 | 2019 | 37 | 0.170 |
Why?
|
| Sex Factors | 3 | 2020 | 643 | 0.160 |
Why?
|
| Probability | 2 | 2009 | 79 | 0.160 |
Why?
|
| Northwestern United States | 2 | 2017 | 53 | 0.160 |
Why?
|
| Episode of Care | 2 | 2012 | 14 | 0.160 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 64 | 0.160 |
Why?
|
| Guideline Adherence | 1 | 2019 | 155 | 0.160 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 48 | 0.150 |
Why?
|
| Efficiency | 4 | 2007 | 13 | 0.150 |
Why?
|
| Utilization Review | 1 | 2018 | 53 | 0.150 |
Why?
|
| Insurance Claim Review | 2 | 2012 | 61 | 0.150 |
Why?
|
| Population Surveillance | 3 | 2017 | 263 | 0.150 |
Why?
|
| Sex Offenses | 1 | 2017 | 8 | 0.150 |
Why?
|
| Patient Admission | 1 | 2018 | 72 | 0.150 |
Why?
|
| Skin Diseases | 1 | 2017 | 10 | 0.150 |
Why?
|
| Neoplasms | 1 | 2022 | 438 | 0.150 |
Why?
|
| California | 3 | 2020 | 2284 | 0.140 |
Why?
|
| Psychotherapy, Brief | 1 | 2017 | 20 | 0.140 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 77 | 0.140 |
Why?
|
| Depression, Postpartum | 2 | 2014 | 18 | 0.140 |
Why?
|
| Wounds, Gunshot | 1 | 2017 | 19 | 0.140 |
Why?
|
| Poisoning | 1 | 2016 | 4 | 0.140 |
Why?
|
| Community Health Services | 1 | 2017 | 83 | 0.140 |
Why?
|
| Stakeholder Participation | 1 | 2016 | 21 | 0.140 |
Why?
|
| Outcome and Process Assessment (Health Care) | 2 | 2007 | 102 | 0.140 |
Why?
|
| African Americans | 1 | 2019 | 472 | 0.140 |
Why?
|
| Overweight | 2 | 2009 | 269 | 0.130 |
Why?
|
| Epidemiologic Research Design | 1 | 2016 | 18 | 0.130 |
Why?
|
| Alcoholism | 1 | 2019 | 347 | 0.130 |
Why?
|
| Anxiety | 1 | 2017 | 150 | 0.130 |
Why?
|
| Body Image | 3 | 2010 | 21 | 0.130 |
Why?
|
| Psychometrics | 3 | 2020 | 121 | 0.130 |
Why?
|
| Stress, Psychological | 1 | 2017 | 141 | 0.130 |
Why?
|
| Drug Utilization | 2 | 2006 | 127 | 0.120 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2015 | 53 | 0.120 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 86 | 0.120 |
Why?
|
| Research | 1 | 2014 | 64 | 0.120 |
Why?
|
| Professional-Patient Relations | 2 | 2006 | 47 | 0.120 |
Why?
|
| Weight Gain | 1 | 2016 | 173 | 0.120 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 28 | 0.120 |
Why?
|
| Energy Intake | 2 | 2010 | 101 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 171 | 0.110 |
Why?
|
| Phenotype | 1 | 2013 | 149 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2011 | 218 | 0.110 |
Why?
|
| Medical Record Linkage | 1 | 2012 | 38 | 0.100 |
Why?
|
| Patient Selection | 1 | 2014 | 190 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2012 | 190 | 0.100 |
Why?
|
| Global Health | 2 | 2002 | 33 | 0.100 |
Why?
|
| Rhode Island | 1 | 2011 | 2 | 0.100 |
Why?
|
| Insurance Coverage | 1 | 2012 | 106 | 0.100 |
Why?
|
| Peru | 3 | 2017 | 6 | 0.100 |
Why?
|
| Referral and Consultation | 2 | 2004 | 167 | 0.100 |
Why?
|
| Health Services Needs and Demand | 1 | 2012 | 93 | 0.100 |
Why?
|
| Online Systems | 1 | 2011 | 8 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2011 | 38 | 0.090 |
Why?
|
| Nurse Practitioners | 1 | 2011 | 19 | 0.090 |
Why?
|
| Health Status Indicators | 1 | 2011 | 64 | 0.090 |
Why?
|
| Insurance, Health | 1 | 2012 | 181 | 0.090 |
Why?
|
| Motor Activity | 2 | 2010 | 212 | 0.090 |
Why?
|
| Women | 1 | 2010 | 12 | 0.090 |
Why?
|
| Program Evaluation | 2 | 2002 | 223 | 0.090 |
Why?
|
| Quality of Life | 3 | 2018 | 507 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2010 | 88 | 0.090 |
Why?
|
| Medical Records | 2 | 2007 | 100 | 0.090 |
Why?
|
| Family Therapy | 1 | 2009 | 6 | 0.080 |
Why?
|
| Task Performance and Analysis | 2 | 2006 | 11 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 2 | 2018 | 33 | 0.080 |
Why?
|
| Age Distribution | 1 | 2009 | 246 | 0.080 |
Why?
|
| Bulimia Nervosa | 1 | 2008 | 10 | 0.080 |
Why?
|
| Child Abuse, Sexual | 1 | 2008 | 14 | 0.080 |
Why?
|
| Interview, Psychological | 1 | 2008 | 19 | 0.080 |
Why?
|
| Health Plan Implementation | 1 | 2009 | 36 | 0.080 |
Why?
|
| Food Preferences | 1 | 2008 | 25 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 119 | 0.080 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2008 | 3 | 0.080 |
Why?
|
| Sampling Studies | 3 | 2004 | 51 | 0.080 |
Why?
|
| Data Collection | 2 | 2006 | 256 | 0.070 |
Why?
|
| Body Height | 1 | 2008 | 62 | 0.070 |
Why?
|
| Occupational Health | 1 | 2007 | 17 | 0.070 |
Why?
|
| Self Concept | 1 | 2008 | 39 | 0.070 |
Why?
|
| Commerce | 1 | 2008 | 48 | 0.070 |
Why?
|
| Social Adjustment | 1 | 2007 | 15 | 0.070 |
Why?
|
| Aging | 1 | 2008 | 161 | 0.070 |
Why?
|
| Seasons | 1 | 2007 | 102 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 57 | 0.070 |
Why?
|
| United States Food and Drug Administration | 1 | 2006 | 34 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 304 | 0.070 |
Why?
|
| Long-Term Care | 1 | 2006 | 22 | 0.070 |
Why?
|
| Meta-Analysis as Topic | 1 | 2006 | 32 | 0.070 |
Why?
|
| Personality Inventory | 1 | 2006 | 14 | 0.070 |
Why?
|
| Insurance, Psychiatric | 1 | 2006 | 2 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 98 | 0.070 |
Why?
|
| Recurrence | 2 | 2007 | 186 | 0.070 |
Why?
|
| Infant | 2 | 2020 | 1171 | 0.070 |
Why?
|
| Pain | 1 | 2006 | 79 | 0.070 |
Why?
|
| Death Certificates | 1 | 2006 | 19 | 0.070 |
Why?
|
| Psychomotor Agitation | 1 | 2005 | 1 | 0.070 |
Why?
|
| Treatment Refusal | 1 | 2006 | 33 | 0.060 |
Why?
|
| Aftercare | 1 | 2006 | 49 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2005 | 24 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2002 | 154 | 0.060 |
Why?
|
| Patient Discharge | 1 | 2007 | 154 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2005 | 81 | 0.060 |
Why?
|
| Social Behavior | 1 | 2005 | 23 | 0.060 |
Why?
|
| Emotions | 1 | 2005 | 34 | 0.060 |
Why?
|
| Albuminuria | 1 | 2004 | 38 | 0.060 |
Why?
|
| Diabetic Nephropathies | 1 | 2004 | 26 | 0.060 |
Why?
|
| Secondary Prevention | 3 | 2012 | 47 | 0.060 |
Why?
|
| Acupuncture | 1 | 2004 | 2 | 0.060 |
Why?
|
| Naturopathy | 1 | 2004 | 5 | 0.060 |
Why?
|
| Chiropractic | 1 | 2004 | 10 | 0.060 |
Why?
|
| Interprofessional Relations | 1 | 2004 | 22 | 0.060 |
Why?
|
| Massage | 1 | 2004 | 18 | 0.060 |
Why?
|
| Disability Evaluation | 2 | 2009 | 46 | 0.060 |
Why?
|
| Lithium Compounds | 1 | 2003 | 1 | 0.060 |
Why?
|
| Antimanic Agents | 1 | 2003 | 2 | 0.060 |
Why?
|
| Valproic Acid | 1 | 2003 | 3 | 0.060 |
Why?
|
| Fluoxetine | 2 | 2003 | 26 | 0.060 |
Why?
|
| Physical Fitness | 1 | 2004 | 73 | 0.060 |
Why?
|
| Apgar Score | 1 | 2002 | 5 | 0.050 |
Why?
|
| Fathers | 1 | 2022 | 10 | 0.050 |
Why?
|
| Gestational Age | 1 | 2002 | 111 | 0.050 |
Why?
|
| Health Behavior | 3 | 2010 | 359 | 0.050 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2022 | 22 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 748 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 949 | 0.050 |
Why?
|
| Hospitalization | 1 | 2007 | 797 | 0.050 |
Why?
|
| Mothers | 1 | 2022 | 105 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2021 | 20 | 0.050 |
Why?
|
| Pregnancy Outcome | 1 | 2002 | 154 | 0.050 |
Why?
|
| World Health Organization | 1 | 2001 | 14 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 86 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2001 | 60 | 0.050 |
Why?
|
| Job Satisfaction | 1 | 2001 | 20 | 0.050 |
Why?
|
| Taiwan | 1 | 2020 | 33 | 0.050 |
Why?
|
| Morbidity | 1 | 2020 | 59 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 243 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2010 | 1267 | 0.040 |
Why?
|
| Ethnopsychology | 1 | 1999 | 1 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2020 | 70 | 0.040 |
Why?
|
| Family Practice | 1 | 2000 | 44 | 0.040 |
Why?
|
| Normal Distribution | 1 | 2019 | 6 | 0.040 |
Why?
|
| Remission Induction | 1 | 2019 | 25 | 0.040 |
Why?
|
| Desipramine | 1 | 1999 | 1 | 0.040 |
Why?
|
| Imipramine | 1 | 1999 | 2 | 0.040 |
Why?
|
| Health Policy | 1 | 2000 | 122 | 0.040 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 1999 | 4 | 0.040 |
Why?
|
| Acute Disease | 1 | 2000 | 142 | 0.040 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 1999 | 28 | 0.040 |
Why?
|
| Adaptation, Psychological | 2 | 2012 | 77 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 121 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 39 | 0.040 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2018 | 53 | 0.040 |
Why?
|
| Research Report | 1 | 2017 | 22 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 318 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2020 | 844 | 0.040 |
Why?
|
| Intimate Partner Violence | 1 | 2017 | 11 | 0.040 |
Why?
|
| Intersectoral Collaboration | 1 | 2017 | 13 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2017 | 39 | 0.040 |
Why?
|
| Linear Models | 2 | 2010 | 231 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2018 | 309 | 0.030 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 2014 | 3 | 0.030 |
Why?
|
| Insurance Claim Reporting | 1 | 2014 | 7 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2014 | 66 | 0.030 |
Why?
|
| Interpersonal Relations | 2 | 2004 | 42 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2014 | 128 | 0.030 |
Why?
|
| Numbers Needed To Treat | 1 | 2012 | 2 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2012 | 68 | 0.030 |
Why?
|
| Vaginal Smears | 1 | 2010 | 48 | 0.020 |
Why?
|
| Eating | 1 | 2010 | 37 | 0.020 |
Why?
|
| Educational Status | 1 | 2010 | 200 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2009 | 35 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2008 | 27 | 0.020 |
Why?
|
| Mammography | 1 | 2010 | 169 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2008 | 64 | 0.020 |
Why?
|
| Observer Variation | 1 | 2008 | 37 | 0.020 |
Why?
|
| Self Disclosure | 1 | 2008 | 22 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2007 | 38 | 0.020 |
Why?
|
| Age of Onset | 1 | 2007 | 79 | 0.020 |
Why?
|
| Home Care Services | 1 | 2007 | 22 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2007 | 44 | 0.020 |
Why?
|
| Demography | 1 | 2007 | 101 | 0.020 |
Why?
|
| Health Education | 1 | 2007 | 111 | 0.020 |
Why?
|
| Occupations | 1 | 2006 | 16 | 0.020 |
Why?
|
| Workplace | 1 | 2006 | 30 | 0.020 |
Why?
|
| Motivation | 1 | 2007 | 130 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2007 | 297 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 80 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2005 | 17 | 0.020 |
Why?
|
| Exercise | 1 | 2010 | 489 | 0.020 |
Why?
|
| Hypertriglyceridemia | 1 | 2004 | 13 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2004 | 17 | 0.020 |
Why?
|
| Attention | 1 | 2004 | 10 | 0.020 |
Why?
|
| Carbamazepine | 1 | 2003 | 3 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2003 | 155 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2002 | 159 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2004 | 268 | 0.010 |
Why?
|
| Life Style | 1 | 2004 | 332 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2003 | 709 | 0.010 |
Why?
|
| Medicare | 1 | 2002 | 202 | 0.010 |
Why?
|